WRITER Guenther Stadler

Comprehensive diagnostics and analysis have transformed dry eye disease (DED) from a subjective complaint into a measurable condition, as Guenther Stadler explains.

Dry eye disease has become one of the most common and clinically demanding conditions in contemporary eye care. Rising screen exposure, environmental stressors, contact lens wear, and an ageing population continue to increase patient presentations across practices. Despite this prevalence, dry eye is still frequently managed at a symptomatic level rather than through comprehensive functional diagnosis.

This gap between symptoms and structured understanding represents one of the biggest challenges in modern ocular surface management.

Dry eye disease is multifactorial. It may involve meibomian gland dysfunction, aqueous deficiency, inflammatory processes, blink abnormalities, or a combination of these factors. Patients often present with similar complaints, burning, fluctuating vision, irritation or visual fatigue – yet the underlying mechanisms can differ significantly. Without objective differentiation, treatment risks becoming repetitive and inconsistent.

Traditional diagnostic approaches, such as slit lamp assessment, fluorescein staining, and symptom questionnaires, remain valuable tools. However, they provide only a partial view of tear film dynamics and gland function. As patient expectations shift toward evidence-based and technology-supported care, many practices are recognising the need for more structured, data-driven dry eye assessment.

Comprehensive diagnostics now enable clinicians to evaluate non-invasive tear break-up time, tearfilm stability, meibomian gland morphology, tear meniscus height, ocular redness, demodex screening, and blink analyses within an integrated workflow. This multi-parameter analysis transforms dry eye from a subjective complaint into a measurable condition. It also significantly enhances patient communication and education. When eye care professionals can visualise the results and present this in an easy-to-understand way to the patient, compliance and engagement increase dramatically.

A growing number of technology providers are supporting this evolution toward structured ocular surface management. ESW Vision, for example, has developed integrated diagnostic and therapeutic platforms designed to support comprehensive dry eye workflows and management. By combining multi-parameter screening with targeted treatment technologies addressing meibomian gland dysfunction, the company’s platforms align with a broader shift toward proactive and measurable dry eye care.

THE ‘EYE FITNESS’ APPROACH

This structured philosophy is increasingly described as an ‘eye fitness’ approach. Eye fitness is a model that views the ocular surface as a functional system requiring regular assessment, optimisation, and long-term monitoring. Rather than treating dry eye episodically, eye fitness promotes a cycle of measurement, education, and targeted intervention.

Such an approach reflects wider healthcare trends emphasising prevention and performance over reactive symptom relief. With clear diagnostic insight, clinicians can determine whether evaporative mechanisms dominate, whether aqueous production is insufficient, or whether inflammatory components require intervention.

Treatment strategies can then extend beyond artificial tears to include thermal therapies, intense regulated pulsed light treatments, and structured maintenance programs.

Comprehensive understanding, then, is central to clinical excellence. Practices that integrate objective diagnostics and defined management pathways are not only improving patient outcomes but also differentiating themselves in an increasingly competitive environment, thereby creating patient loyalty.

Dry eye disease is chronic and progressive in many cases. Managing it effectively requires more than lubrication; it requires clarity and a clear dry eye management strategy. A complete understanding of tear film function, tear film stability and gland health may well define the next standard of care in ocular surface management.

This article is sponsored by ESW Vision.

Guenther Stadler is an optometrist and Product Manager at ESW Vision, bringing extensive international experience in the optical and ophthalmology industries.
ESW Vision is focused on advanced and accessible dry eye management solutions for both ophthalmic and optometry markets.